National Health Determination under paragraph 98C(1)(b) Amendment 2016 (No. 4) (PB 44 of 2016)

Overview

The National Health Determination under paragraph 98C(1)(b) Amendment 2016 (No. 4) (PB 44 of 2016) was enacted to amend the existing National Health Determination under paragraph 98C(1)(b) of the National Health Act 1953. This amendment was introduced to rectify a typographical error in Schedule 3 of the Principal Determination without causing any disadvantage to individuals. The determination is a legislative instrument that sets out the conditions under which payments will be made in respect of the supply of pharmaceutical benefits by approved pharmacists and approved medical practitioners, forming part of the legislative basis for the Pharmaceutical Benefits Scheme (PBS). The Minister has the authority to determine these conditions under paragraph 98C(1)(b) of the Act, and this amendment ensures the ongoing integrity and effectiveness of the scheme by correcting the identified error. The enactment of this Amendment Determination by the Australian Government addresses a specific issue within the existing regulatory framework without requiring additional consultation, as no individual has been disadvantaged by the typographical error. This legislative instrument is compatible with human rights, as it aids in the progressive realization of the right to the highest attainable standard of physical and mental health by ensuring the PBS continues to provide reliable, timely, and affordable access to a wide range of medicines for all Australians. The amendment aligns with Articles 2 and 12 of the International Covenant on Economic, Social and Cultural Rights (ICESCR) and is consistent with the evidence-based decisions made by the Pharmaceutical Benefits Advisory Committee (PBAC).

Scope and Application

The National Health Determination under paragraph 98C(1)(b) Amendment 2016 (No. 4) rectifies a typographical error in the Principal Determination (PB 119 of 2008) concerning the conditions under which payments will be made by the Commonwealth for the supply of pharmaceutical benefits by approved pharmacists and approved medical practitioners. This Amendment Determination is an essential correction within the framework of the National Health Act 1953, ensuring that the terms of the Pharmaceutical Benefits Scheme (PBS) remain accurate and effectively implemented. It applies to all entities and individuals involved in the supply of pharmaceutical benefits under the PBS, thereby maintaining the integrity of the scheme without disadvantaging any party due to the error. The amendment is subject to the conditions outlined in the National Health Act 1953, and its scope is limited to the correction of the identified typographical error, with no other substantive changes to the legislative framework.

Key Provisions

The main operative sections of the Amendment Determination are those that modify the Principal Determination (PB 119 of 2008) under the National Health Act 1953 (the Act). Specifically, the amendment rectifies a typographical error in Schedule 3 of the Principal Determination, which sets out the conditions subject to which payments will be made in respect of the supply of pharmaceutical benefits by approved pharmacists and approved medical practitioners (paragraph 98C(1)(b)). The determination itself is a legislative instrument for the purposes of the Legislation Act 2003 and is compatible with human rights as it advances the protection of human rights by ensuring that the Pharmaceutical Benefits Scheme (PBS) provides reliable, timely, and affordable access to a wide range of medicines for all Australians. The Amendment Determination imposes obligations on the parties and entities it governs by requiring compliance with the corrected conditions set out in the amended Schedule 3 of the Principal Determination. The Pharmaceutical Benefits Advisory Committee (PBAC) must continue to ensure that decisions about subsidised access to medicines on the PBS are evidence-based, and approved pharmacists and approved medical practitioners must adhere to the conditions for making claims under the PBS. The Minister for Health is responsible for determining the conditions under which payments will be made in respect of the supply of pharmaceutical benefits by approved pharmacists and approved medical practitioners, and this responsibility is now accurately reflected in the amended Schedule 3. The Amendment Determination does not introduce new offences, penalties, or civil/criminal consequences for breach. However, it is essential that the parties and entities governed by the Principal Determination comply with the corrected conditions to avoid potential issues related to the processing and payment of claims under the PBS. The Principal Determination already outlines the penalties and consequences for non-compliance, which may include financial penalties, recovery of payments, or exclusion from the PBS. The amendments to the Principal Determination do not alter these existing consequences, but they ensure that the conditions under which payments are made are accurately reflected and that no person has been disadvantaged as a result of the typographical error. In summary, the Amendment Determination rectifies a typographical error in the Principal Determination under the National Health Act 1953, ensuring that the conditions subject to which payments will be made by the Commonwealth in respect of the supply of pharmaceutical benefits by approved pharmacists and approved medical practitioners are accurately reflected. The Amendment Determination imposes obligations on the parties and entities governed by the Principal Determination to comply with the corrected conditions, and it is compatible with human rights by advancing the protection of the right to the highest attainable standard of physical and mental health. There are no new offences, penalties, or civil/criminal consequences for breach, but compliance with the amended conditions is essential to avoid potential issues related to the processing and payment of claims under the PBS.